Skip to content
GLP-1 Savers
Menu
Ranked #286 · Watch List

Aurelius Health Group review

Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $199/mo

Save ~85% vs brand-name

From $199/mo (microdose tier, compounded)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a single-tier rate, not a price that is guaranteed at every dose.

How much does Aurelius Health Group cost?

The price Aurelius Health Group publishes is From $199/mo (microdose tier, compounded). We flag this one to watch: confirm the ongoing rate with Aurelius Health Group before you count on it, because a low first month can step up afterward. That works out about 85% under our ~$1,349/mo brand-name cash reference.

Semaglutide
Not disclosed
Tirzepatide
From $199/mo (microdose tier, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

The Value Score card

Aurelius Health Group scored on our six published factors. See the methodology.

Lowest Real Price72/100
No Teaser-Rate Bait64/100
Nationwide Availability45/100
Both Molecules62/100
Easy Cancellation95/100
Reputation54/100

Why it's a deal

  • Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
  • LegitScript Certified
  • Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
  • Unusually candid about the limited evidence base for microdosing

Read the fine print

  • The advertised $89 is a first-month new-patient rate; every month after it is $199
  • This is a 1 mg microdose program and nothing else — no labeled therapeutic dose is sold, so it is not an alternative to a full-dose prescription
  • No state count is published, only 'most US states', confirmed at intake
  • The site's own comparison table calls 2.4 mg/week the tirzepatide 'standard full dose'; 2.4 mg is the semaglutide maintenance dose, and tirzepatide is labeled 2.5-15 mg/week
  • Compounded tirzepatide is not an FDA-approved finished product

The bottom line

Best for: Shoppers who want transparent, care-inclusive compounded tirzepatide microdosing. Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+.

Ranked #286 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Aurelius Health Group, out of 426 others we track.

Shopping Aurelius Health Group against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Aurelius Health Group, and every program that undercuts or outscores it — starting with VevaRX, the closest match on score — is ranked on the Aurelius Health Group alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Aurelius Health Group's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Aurelius Health Group's site. Not medical advice; see our disclosure.

Where Aurelius Health Group ranks

See every program ranked by price →

← Back to all deals